Search results for " CDMOs"
								 					Article
				
				CDMOs Driving Emerging Bio/Pharma Success
								CDMOs Driving Emerging Bio/Pharma Success
	CDMOs can claim credit for the robust growth of emerging bio/pharma financings. 
	
		By Jim Miller 
		
	
	
		
	
	
		Emerging bio/pharmaceutical companie…								
								 					Article
				
				The Role of CDMOs in Cell and Gene Therapy Process Development
								
	Click here to read more >>
	
An experienced contract development and manufacturing organization (CDMO) can ease scaling and tech transfer.								
								 					Article
				
				Step Up to GMP Manufacturing or Outsource to a CDMO: Considerations and Tips
								Whether you are developing a new monoclonal antibody (mAb), cell therapy, gene therapy, or large-molecule biologic drug, the decision to tackle GMP manufacturing in-house or work with a contract devel…								
								 					Article
				
				Is Not Using a CDMO Slowing Down Your Process Development?
								
	Consider what process development capabilities you have versus what you could possibly gain from working with a CDMO to not only be successful, but also to improve your chances of getting to market …								
								 					Article
				
				Contract Manufacturing Through the Years
								
	
		Contract Manufacturing Through the YearsHow has the bio/pharmaceutical contract manufacturing industry evolved over the years and what does the future hoHow has the bio/pharmaceutical contract ma…								
								 					Article
				
				Maximum Output Starts with Optimized Upstream Processing
								
	By Cynthia A. Challener 
	
	Biopharmaceutical companies and contract manufacturers respond to changing demand dynamics for upstream bioprocessing capacity. 
	
	Significant growth in the develo…								
								 					Article
				
				Strategizing for Rapid Changeovers in Biologics Manufacturing
								
	Olivier Le Moal/Stock.Adobe.com
	
 
	By Cynthia A. Challener  
	Facility and equipment design are important, but the team and its experience matter most. 
	Through its Operation Warp Speed pro…								
								 					Article
				
				Climate Change in Outsourcing
								
	As 2013 draws to a close, the bio/pharmaceutical industry continues to be reshaped by changes in the business climate. Financial, political, and scientific developments that began 10 years ago conti…								
								 					Article
				
				The Tide Stays High
								
	Robust venture capital investment gives CDMOs and CROs a positive outlook for 2017. 
	By Jim Miller 
	A year ago, the outlook for contract services was a little uncertain. Equity markets’ appeti…								
								 					Article
				
				Evolving demands of process development services
								
	 
	
	
	Shifting demands from industry innovators is leading to an increased need for flexible and agile outsourcing partners offering broad and integrated models. 
	
	
	Over the years and in light o…